About us | Advertise with us | Contact us
Posted: 31 March 2022 | Hannah Balfour (European Pharmaceutical Review) | No comments yet
Lot 31329657B of Teva’s IDArubicin Hydrochloride Injection USP 5mg/5ml vials is being recalled across the US due to particulates.
Teva is voluntarily recalling lot 31329657B of IDArubicin Hydrochloride Injection USP 5mg/5ml vial, to the user level in the US. The nationwide recall was initiated after an internal internal inspection found particulate matter in one vial of the product identified as silica and iron oxide. No other vials have been observed to contain this defect and, to date, Teva has received no product quality complaints or adverse event reports of this nature for the subject recall lot.
The administration of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign material. If the particulate matter reaches the blood vessels it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. While the health hazard risk could be severe if particulate matter is infused, Teva’s internal health assessment determined that the likelihood of patient harm is remote or unlikely.
IDArubicin Hydrochloride Injection USP, in combination with other approved anti-leukaemic drugs, is indicated for the treatment of acute myeloid leukaemia (AML) in adults.
Information on the affected product is below:
IDArubicin Hydrochloride Injection USP 5mg/5ml vial
Vial/Carton NDC: 0703-4154-11
Teva distributed 1,565 5ml single dose vials nationwide between 4 December 2020 and 18 August 2021 to 4 wholesaler customers. The company notified its customers of the recall on 28 March 2022, asking them to make arrangements for impacted product to be returned. Instructions for returning recalled product and crediting are given in the recall letter released by Teva.
This recall was made with the knowledge of the US Food and Drug Administration (FDA). Teva will continue to partner with, and regularly update, all relevant stakeholders, including regulatory authorities, to resolve this situation.
Blood pressure tablets recalled due to high levels of nitrosamine…
Big Pharma, Drug Safety, Impurities, QA/QC, Regulation & Legislation, Therapeutics
Teva Pharmaceuticals, US Food and Drug Administration (FDA)
By Hannah Balfour (European Pharmaceutical Review)
Big Pharma, Drug Safety, Impurities, QA/QC, Regulation & Legislation, Therapeutics
Teva Pharmaceuticals, US Food and Drug Administration (FDA)
All subscriptions include online membership, giving you access to the journal and exclusive content.
By Anna Begley (European Pharmaceutical Review)
By Anna Begley (European Pharmaceutical Review)
By Dave Elder (David P Elder Consultancy)
By Mandy Parrett (European Pharmaceutical Review)
Your email address will not be published. Required fields are marked *
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Write for us | Advertise with us
European Pharmaceutical Review is published by: Russell Publishing Ltd. Court Lodge Hogtrough Hill Brasted, Kent, TN16 1NU United Kingdom
© Russell Publishing Limited, 2010-2022. All rights reserved.
Website development by e-Motive Media Limited.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
CookieDescriptioncookielawinfo-checkbox-advertising-targetingThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".cookielawinfo-checkbox-analyticsThis cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".cookielawinfo-checkbox-necessaryThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".cookielawinfo-checkbox-performanceThis cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".PHPSESSIDThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.viewed_cookie_policyThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.zmember_loggedThis session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.